death cross chart , page-25

Hi Amg,

"Shareholders pour in their hard earned cash and management choose to ignore shareholders, leave shareholders in the dark for the most part of last year"

You do realise that it is only in the last year management have disclosed the names of The Procter and Gamble Company and Coty Inc. to its s/holders? - That makes two in the past year, and a total of four in the past nine years.

Just stating the facts, sorry ;)

___________________

Hi paprika,

"It's a pity you didn't instead find a study which looked at the price for individual stocks and 2-4 weeks after a death cross as that is when support will be reached and/or breached for OBJ."

The S&P500 represents 500 "individual stocks" and as you initially posted, "In my opinion, this [OBJ] is not a long term buy..." that study is quite relevant to the 'Long Term' debate, which concludes, "In the 12 months following each of its 32 macabre manifestations, the Death Cross has spooked investors to an average gain on the S&P 500 of 3.8%. Not very scary."

Now you're suggesting to only compare "individual" stocks 2-4 weeks post this signal, so what's your basis for OBJ not being a Long Term Buy?

As i'm not a trader the short term noise is not of much interest to me, however could one not also argue that the sp of OBJ is currently sitting at a 30% discount to the one month VWAP of 2c, and is also just above the oversold line which also represents a short, medium and long term buy opportunity?

As for TON, the stock is currently a traders play thing so certain technical indicators may be more reliable - It's difficult to rely on the technicals for a stock like OBJ where there is little volume.

Arguably, one could also ask how many more times the market is going to factor in the CR, or when the market may begin to factor in any value for the considerable volume of activity that is being neglected...

26/10/2012: Notice of AGM - 15.38%
26/11/2012: Results of AGM - 7.69%
06/12/2012: P&G Progresses to Clinical Trials + 6.25%
22/02/2013: Exclusive Collaboration with Coty 0.00%
28/02/2013: Non-Renounceable Rights Issue - 28.69%
15/03/2013: Rights Issue Prospectus - 14.29%
21/03/2013: Key Dermaportation Grant - 7.10%
____________________

Hi Southoz,

Rumour has it that Surges was assumed to be Jeff, and myself, Glyn, or it may have been the other way around, however just for the record, Surges and I are not a "married couple" and nor are Jeff and Glyn ;)
____________________

Hi Jeff Surges,

"Several investors I know personally indeed showed an interest in OBJ due to the P&G partnership. That is hardly surprising. We discussed the company on several occasions. Evidently, they have not committed. So much is clear. The lack of overseas commitment, when OBJ partners in the US as well as in the UK, is actually representing one major criticism from my side."

I'm happy to put to rest that which represents one major criticism from your side...

"The securities of OBJ cannot be sold in the United States unless the securities are registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, registration." - 30/11/2012 - AGM Presentation